The federal government plans to disburse $1.1 billion for comparative effectiveness research. But who gets the funding and what studies are to be conducted remain undetermined.
As rising health care costs continue to strain the Medicare and Medicaid budgets, the government has become interested in comparative effectiveness research, which promises to provide quality data about the costs and benefits of various treatment options. The economic gains that may derive from such study have caused some to question whether it will be used to justify health care rationing. But members of a federal council that will coordinate the research and make funding suggestions said they will not be recommending clinical guidelines for payment, coverage, or treatment.
Mitka M. Studies Comparing Treatments Ramp Up. JAMA. 2009;301(19):1975. doi:10.1001/jama.2009.671